Udi Gafni CEO 18 years experience in medical device arena Co founder former CEO of Medoc Ltd medical device
| THE NEED.There are one billion people with hypertension, yet barely half have been diagnosed. Among the diagnosed cases, only 20% are controlled (with medication). Untreated and poorly managed cardiovascular disease (CVD) is the No. 1 killer in the world. Early detection combined with effective control is critical for saving millions of lives and reducing related disability. Existing blood pressure (BP) monitoring devices provide only limited information to the physician.
There is a need for a more accurate and informative measurement that properly reflects the cardiovascular system and its haemodynamics. Continuous parameters such as cardiac output, central BP, arterial stiffness, peripheral resistance, and endothelial function are essential for effective drug treatment and controlling CVD. n OUR SOLUTION.CardioSigns’ lightweight, reliable, non-invasive wrist device is the only system that analyzes pulse shape and blood pressure with the frequency needed to effectively detect and treat hypertension and CVD. The CardioSigns wrist device provides accurate clinical data while being comfortable for the patient. Data from the system’s clinical interpretation software can be used, either locally or via telehealth networks to deliver real-time alerts to patients or caregivers about critical CVS events (BP drop, heart attack or stroke), enabling improved emergency and long-term treatment. Mobile and Web connectivity provide the versatile, affordable solution that can be adapted for applications in hospitals, clinics, and the home.n TECHNOLOGY.CardioSigns’ unique Pressure Cardiogram (PCG) technology is a proprietary platform that provides clinicians with a comprehensive assessment of the cardiovascular system’s haemodynamics for understanding and treating cardiovascular diseases. The CardioSigns technology uses multiple sensors and actuators with sophisticated algorithms to offer advantages including –
n MARKET. CardioSigns is addressing a number of large and growing markets including:
The Company will first develop a solution for the professional market — to receive clinical validation and recognition — while progressing toward its vision of becoming a key element of the primary care and telehealth arena. n INVESTORS & STRATEGIC PARTNERS. CardioSigns is looking for strategic partnerships with:
CardioSigns is seeking a $5 million investment to advance product development and commercialization, and for business development. |
n CONTACT INFORMATION Ehud (Udi) Gafni, CEO Tel: +972.4.903 8800 n MANAGEMENT Udi Gafni, CEO. 18 years experience in Medical device arena; Co-founder, former CEO of Medoc Ltd., Medical device manufacturer, since 1990; positions in leading companies including Rafael Advanced Defense Systems, C.I. Systems, Iscar; B.Sc., M.Sc., Technion – Israel Institute of Technology. Dr. Ehud Baron, CSO, Chairman of the Board. In-depth Medical knowledge, technological and business experience; founded several companies including Baron Technologies, InVibro, LaseRays and InMotion; holds 50 patents; involved in new drug clinical trials, Roche; M.D., D.Sc. in signal processing, machine learning, Technion – Israel Institute of Technology; M.A. ,statistics and psychology ,Hebrew University of Jerusalem Haim Lilos CFO, Director - CPA, extensive business, finance experience Amir Haiman, R&D Manager. Development experience in Medical device field; VP Development, Medoc; involved in CardioSigns development from early stage; position in development at Itamar Medical; B.Sc., electrical engineering, Ruppin Academic College of Engineering Clinical Advisory board Led by Professor. Gad Keren, M.D., Chairman, Cardiology Department, Tel Aviv Medical Center; involved in several cardiology start-ups Prof. Amir Landesberg. M.D., D.Sc. Head, Cardiovascular Research Center, Faculty of Biomedical Engineering, Technion n COMPANY STATUS Founded: 2008 Seed investor: Medoc Ltd. n INTELLECTUAL PROPERTY Provisional patent application, April 2008 n DEVELOPMENT STATUS
|
MarketReach America is a partnership of the Maryland/Israel Development Center and The Trendlines Group
© 2008 All rights reserved.
See all the reviews